In the case of mRNA cancer vaccines, this false narrative could undermine public confidence in an important tool that may help prevent or treat cancer in the future. Most people likely first heard ...

Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a study presented at the European Oncology meeting. Messenger RNA (mRNA) ...

Each Thursday, we bring you updates on health policy, community surveys, new clinical studies, programs and services in Southwest and Southside Virginia. Got a tip or story idea? Email me at ...

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

The ECDC, the infectious diseases watchdog, has asked for scientists to join its new panel on RSV as Europe begins to vaccinate its most vulnerable adults.

The vaccine could replace the need for separate annual jabs for flu, Covid and cold viruses as well as providing defence against new pathogens ...

Researchers show how LGP2 binds viral RNA ends, moves along the strand, and helps MDA5 form filaments that amplify antiviral signaling. The findings clarify an early defense step and may inform ...